SCHEMBL4424911

SCHEMBL4424911

CC(C)(C)OC(=O)C(N)c1cc2cc(C(=O)O)ccc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
PTGER1 P34995 1/20 0.37
PTGER3 P43115 1/20 0.37
PTGER2 P43116 1/20 0.37
PTGDR Q13258 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GRM1 Q13255 2/20 0.37
CYP1A2 P05177 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.36
TBXAS1 P24557 1/20 0.36
PIM1 P11309 3/20 0.36
PIM2 Q9P1W9 1/20 0.35
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976859 0.77 TP53 (0.43) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL22672601 0.74 TP53 (0.47) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL506934 0.73 ANPEP (0.45) TP53MEN1KMT2AALDH1A1GRM1
SCHEMBL1257100 0.73 TP53 (0.46) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL27789721 0.73 GRM1 (0.66) MEN1KMT2AHSD17B10GRM1CYP1A2
SCHEMBL6983542 0.73 PIM1 (0.55) TP53MEN1KMT2AKDM4EALDH1A1
SCHEMBL6397712 0.72 GRM1 (0.46) MEN1KMT2AKDM4EALDH1A1GRM1
SCHEMBL2446139 0.72 GRM1 (0.46) MEN1KMT2AGRM1CYP1A2TDP1
SCHEMBL27499603 0.72 KMT2A (0.46) MEN1KMT2AALDH1A1GRM1CYP1A2
SCHEMBL27618814 0.72 GRM1 (0.46) MEN1KMT2AGRM1CYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682538-A4 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S BIO PTE LTD (SG) 2009-05-27 EP disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
EP-1682538-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*Bio Pte Ltd (SG) 2006-07-26 EP disclosed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 TP53 1423/4885MEN1 1622/4885KMT2A 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.